Skip to main content
Clinical Trials/NCT03720691
NCT03720691
Not yet recruiting
Not Applicable

Effect of Repetitive Transcranial Magnetic Stimulation in Vascular Parkinsonism

Inje University1 site in 1 country32 target enrollmentDecember 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Vascular Parkinsonism
Sponsor
Inje University
Enrollment
32
Locations
1
Primary Endpoint
Unified Parkinson's Disease Rating Scale (UPDRS) part III-motor part (Number 18 ~31 of UPDRS)
Status
Not yet recruiting
Last Updated
7 years ago

Overview

Brief Summary

Vascular parkinsonism (VP), parkinsonism resulting from ischemic cerebrovascular disease, was suggested in 1929. The main features are wide-based gait, postural instability, and falls, which make patients with VP frustrated. Currently, the treatment is challenging.

Transcranial magnetic stiumation is a noninvasive procedure using electromagnetic induction to stimulate brain, and repetitive transcranial magnetic stiumation (rTMS) can selectively change brain activity to enhance desired effects. The aim of this study is to explore the therapeutic effect of rTMS for the VP.

Registry
clinicaltrials.gov
Start Date
December 2018
End Date
December 2025
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sangjin Kim

Professor

Inje University

Eligibility Criteria

Inclusion Criteria

  • Vascular parkinsonism
  • age 18 and older

Exclusion Criteria

  • pregnant or any, other medical, surgical, neurological or psychiatric conditions
  • other restrictions which prevent you from undergoing TMS recording, such as; surgically or traumatically implanted foreign bodies such as a pacemaker, an implanted medication pump, a metal plate in the skull, or metal inside the skull or eyes (other than dental appliances or fillings), and/ or heart/cardiac lines
  • any past or current history of seizure disorder or epilepsy
  • unable to give informed consent

Outcomes

Primary Outcomes

Unified Parkinson's Disease Rating Scale (UPDRS) part III-motor part (Number 18 ~31 of UPDRS)

Time Frame: 2 days

Motor functions will be checked using UPDRS. Each item of the motor part ranges from 0 to 4 (0 means normal, 4 means worst condition). Total sum will be calculated.

Secondary Outcomes

  • The total number of steps during the stand-walk-sit (SWS) test(2 days)
  • Freezing episodes of gait trajectory(2 days)
  • Finger tapping test with right hand(2 days)
  • The completion time during the SWS test(2 days)
  • Patient and Clinical Global Impression Scale(2 days)

Study Sites (1)

Loading locations...

Similar Trials